0.4215
price down icon3.10%   -0.0135
 
loading
Schlusskurs vom Vortag:
$0.435
Offen:
$0.42
24-Stunden-Volumen:
549.29K
Relative Volume:
0.26
Marktkapitalisierung:
$17.51M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-10.48M
KGV:
-0.669
EPS:
-0.63
Netto-Cashflow:
$-13.77M
1W Leistung:
+12.88%
1M Leistung:
+20.43%
6M Leistung:
-21.94%
1J Leistung:
-86.45%
1-Tages-Spanne:
Value
$0.4144
$0.4394
1-Wochen-Bereich:
Value
$0.3525
$0.445
52-Wochen-Spanne:
Value
$0.2179
$3.3654

Prophase Labs Inc Stock (PRPH) Company Profile

Name
Firmenname
Prophase Labs Inc
Name
Telefon
(215) 345-0919
Name
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Name
Mitarbeiter
96
Name
Twitter
Name
Nächster Verdiensttermin
2025-05-20
Name
Neueste SEC-Einreichungen
Name
PRPH's Discussions on Twitter

Vergleichen Sie PRPH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
PRPH
Prophase Labs Inc
0.4215 18.07M 62.71M -10.48M -13.77M -0.63
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
475.03 176.18B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
202.81 141.70B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
549.97 43.48B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
200.82 33.02B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.35 33.01B 6.63B 1.17B 1.19B 4.05

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-12-20 Eingeleitet H.C. Wainwright Buy
2021-10-13 Herabstufung Dawson James Buy → Neutral
2021-01-20 Eingeleitet Dawson James Buy

Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten

pulisher
01:29 AM

ProPhase Labs Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional

01:29 AM
pulisher
12:18 PM

What analysts say about ProPhase Labs Inc. stockDynamic investment growth - PrintWeekIndia

12:18 PM
pulisher
Jul 24, 2025

How ProPhase Labs Inc. stock reacts to Fed policy changesTremendous growth opportunities - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

ProPhase Labs shares rise 1.15% premarket after closing $3 million senior secured convertible notes financing. - AInvest

Jul 24, 2025
pulisher
Jul 23, 2025

ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

ProPhase Labs secures $3 million in convertible notes financing By Investing.com - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

ProPhase Labs secures $3 million in convertible notes financing - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Prophase Labs Secures $3 Million in Private Financing - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

ProPhase Labs Raises $3M as Bridge to $50M Covid Collections and Crypto Strategy Launch - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Is ProPhase Labs Inc. a good long term investmentDynamic growth stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs explores reverse merger with digital asset company - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan

Jul 21, 2025
pulisher
Jul 20, 2025

What makes ProPhase Labs Inc. stock price move sharplyHigh Potential Safe Trades - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 02, 2025

ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail

Jul 02, 2025
pulisher
Jul 01, 2025

PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan

Jul 01, 2025
pulisher
Jun 26, 2025

Prophase Labs Secures $1M in New Loan Agreements - TipRanks

Jun 26, 2025
pulisher
Jun 26, 2025

ProPhase Labs, Inc. Receives Additional 180 Day Extension from N - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

ProPhase Labs, Inc. Receives Additional 180 Day Extension - GlobeNewswire

Jun 26, 2025
pulisher
Jun 26, 2025

ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener

Jun 26, 2025
pulisher
Jun 25, 2025

Prophase Labs Appoints Carolina Abenante as Director - TipRanks

Jun 25, 2025
pulisher
Jun 25, 2025

ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK

Jun 25, 2025
pulisher
Jun 21, 2025

ProPhase Labs, Inc. announced that it expects to receive $0.5 million in funding - MarketScreener

Jun 21, 2025
pulisher
Jun 17, 2025

ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener

Jun 17, 2025

Finanzdaten der Prophase Labs Inc-Aktie (PRPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$298.47
price up icon 0.96%
diagnostics_research DGX
$171.90
price up icon 0.83%
$141.06
price up icon 2.35%
diagnostics_research LH
$267.69
price up icon 6.86%
diagnostics_research MTD
$1,260.75
price up icon 0.28%
diagnostics_research A
$120.35
price up icon 0.74%
Kapitalisierung:     |  Volumen (24h):